Skip to search.
 BSE Up 0.31% NSE Up 0.50%

ZIOPHARM Oncology, Inc. (ZIOP)

-NasdaqCM
5.67 Up 0.08(1.43%) 2:30am
|After Hours : 5.67 0.00 (0.00%) 3:36am - Nasdaq Real Time Price
Prev Close:5.59
Open:5.55
Bid:5.66 x 300
Ask:5.70 x 1000
1y Target Est:21.00
Beta:1.89433
Earnings Date:22 Feb - 27 Feb (Est.)
Day's Range:5.42 - 5.68
52wk Range:4.45 - 9.74
Volume:1,641,588
Avg Vol (3m):1,992,590
Market Cap:739.73M
P/E (ttm):N/A
EPS (ttm):-1.28
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for ZIOP at this time.

Comparison

Symbol% ChgMkt Cap
ZIOPUp 1.43%739.73M
IMGNUp 2.06%216.51M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):101.56
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.33
Quarterly EPS Est (Dec-16) :-0.11
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ZIOPHARM Oncology, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing a portfolio of cancer therapies that address unmet medical needs through synthetic immuno-oncology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback